Meeting
2021 ASCO Quality Care Symposium
Medicare Part D spending for the 10 costliest oral anticancer drugs.
Authors
Kaitlyn McBride
Qualia Bio, Los Angeles, CA
Kaitlyn McBride, Sophie Snyder
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cost, Value, and Policy; Health Equity and Disparities; Patient Experience
Track
Cost, Value, and Policy,Technology and Innovation in Quality of Care,Health Care Access, Equity, and Disparities,Patient Experience,Quality, Safety, and Implementation Science
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 39, 2021 (suppl 28; abstr 52)
DOI
10.1200/JCO.2020.39.28_suppl.52
Abstract #
52
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
First Author: Nivedita Arora
Poster
2019 ASCO Annual Meeting
Cost of oral cancer drugs: Trends in the United States Medicare population in 2013 and 2015.
First Author: Kira Rose-Madison Seiger
Poster
2021 ASCO Quality Care Symposium
Physician-pharmacy integration and oral cancer drug use and quality.
First Author: Pragya Kakani
Poster
2016 ASCO Annual Meeting
Rising financial burden of targeted oral anticancer medications on the Medicare Part D program and its beneficiaries.
First Author: Ya-Chen T. Shih